Fibroblasts and chondrocytes

Fibroblasts and chondrocytes are specialized mesenchymal cells responsible for the synthesis and maintenance of the extracellular matrix (ECM) in various tissues. Fibroblasts are ubiquitous in connective tissue, where they secrete collagen and play a central role in wound healing and structural support [1]. Chondrocytes are the specialized cells found in cartilage, maintaining the matrix through the production of collagen type II and aggrecan [2]. Pathologically, fibroblasts are the primary drivers of fibrotic diseases when overactivated, while the loss of chondrocyte function or phenotype is a key driver of osteoarthritis [3]. Because "Fibroblasts and chondrocytes" refers to entire cell populations rather than a specific protein or nucleic acid, this entry does not constitute a single therapeutic molecular target. Instead, pharmacological interventions typically target specific signaling pathways, such as the TGF-beta or Wnt pathways, within these cells to modulate their activity in disease states [4]. Therapeutic challenges include achieving cell-type specificity to avoid systemic side effects in other connective tissues. Monitoring these cells often involves biomarkers like alpha-smooth muscle actin for activated fibroblasts or Sox9 for chondrocytes. [1] NIH National Human Genome Research Institute (https://www.genome.gov/genetics-glossary/Fibroblast) [2] StatPearls, "Histology, Chondrocytes" (https://www.ncbi.nlm.nih.gov/books/NBK557422/) [3] Nature Reviews Rheumatology, "Chondrocyte phenotype and osteoarthritis" (https://www.nature.com/articles/nrrheum.2011.39) [4] Journal of Clinical Investigation, "Fibroblasts: therapeutic targets in fibrosis" (https://www.jci.org/articles/view/121906)

Other names

Connective tissue cellsMesenchymal cellsStromal cellsCartilage cells

Not applicable. This entry describes cell types rather than a specific molecular target such as a receptor, enzyme, or transporter.